PCMA Statement on US House Approval of HR 4
January 12, 2007
(Washington, DC)— The Pharmaceutical Care Management Association (PCMA) issued the following statement in response to the US House of Representatives approving HR 4:
“In Medicare Part D, seniors want and deserve broad access to needed medicines, lower costs, and choices about their pharmacy options. Just one year into the new benefit, Part D is providing beneficiaries with deeper-than-expected discounts and low premiums. The program has come in 10 percent under budget because of the intense competition among Medicare drug plans. Seniors are increasingly satisfied with the program, with multiple surveys showing 80 percent-plus satisfaction.
“Regrettably, HR 4 would take the Medicare drug benefit in the wrong direction and potentially shift additional costs to private and public payors, including Medicaid and the Veterans Administration.
“As this debate moves to the US Senate, PCMA looks forward to working constructively with both sides of the aisle to increase awareness about what is working here and now in Part D. PCMA welcomes the opportunity to explore how best to assure seniors broad access to affordable prescriptions, including expanding access to generic drugs and the mail-service pharmacy option.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs), which lower the cost of prescription drugs for more than 200 million Americans with coverage provided through Fortune 500 employers, health insurers, labor unions, and Medicare Part D
Phil Blando, 202-207-3614
Charles Coté 202-207-3605